Literature DB >> 31620584

Preoperative arterial embolization of heterotopic ossification around the hip joint.

Jin Hyeok Kim1, Chankue Park1, Seung Min Son2, Won Chul Shin2, Joo Yeon Jang1, Hee Seok Jeong1, In Sook Lee3, Tae Young Moon1.   

Abstract

Heterotopic ossification (HO) around the hip joint is not uncommon following neurological injury. Often, surgical treatment is performed in patients with restricted motion and/or refractory pain due to grade III or IV HO according to Brooker classification. The major complication that occurs as a result of surgical HO removal is perioperative bleeding due to hyper-vascularization of the lesion. Here, we report a case of preoperative embolization in a 51-year-old male patient presenting with restricted bilateral hip range of motion (ROM) due to HO following a spinal cord injury. In the right hip without preoperative arterial embolization, massive bleeding occurred during surgical removal of HO. Thus, the patient received a transfusion postoperatively due to decreased serum hemoglobin levels. For surgery of the left hip, preoperative embolization of the arteries supplying HO was performed. Surgical treatment was completed without bleeding complications, and the patient recovered without a postoperative transfusion. This case highlights that, while completing surgical removal for ROM improvements, orthopedic surgeons should consider preoperative arterial embolization in patients with hip HO.
Copyright © 2018 Yeungnam University College of Medicine.

Entities:  

Keywords:  Arterial embolization; Gelatin sponge; Heterotopic ossification; Hip

Year:  2018        PMID: 31620584      PMCID: PMC6784659          DOI: 10.12701/yujm.2018.35.1.130

Source DB:  PubMed          Journal:  Yeungnam Univ J Med        ISSN: 2384-0293


  13 in total

1.  The incidence of heterotopic ossification after hip arthroscopy.

Authors:  Asheesh Bedi; Robert M Zbeda; Vinicius F Bueno; Brian Downie; Mark Dolan; Bryan T Kelly
Journal:  Am J Sports Med       Date:  2012-01-20       Impact factor: 6.202

2.  Sensory nerve induced inflammation contributes to heterotopic ossification.

Authors:  Elizabeth Salisbury; Eric Rodenberg; Corinne Sonnet; John Hipp; Francis H Gannon; Tegy J Vadakkan; Mary E Dickinson; Elizabeth A Olmsted-Davis; Alan R Davis
Journal:  J Cell Biochem       Date:  2011-10       Impact factor: 4.429

3.  Preoperative embolization.

Authors:  William S Rilling; Gene W Chen
Journal:  Semin Intervent Radiol       Date:  2004-03       Impact factor: 1.513

Review 4.  A case-based approach to common embolization agents used in vascular interventional radiology.

Authors:  Avinash Medsinge; Albert Zajko; Philip Orons; Nikhil Amesur; Ernesto Santos
Journal:  AJR Am J Roentgenol       Date:  2014-10       Impact factor: 3.959

5.  Preoperative arterial embolization in heterotopic ossification: a case report.

Authors:  T J Vogl; J D Wolff; J Balzer; R Skripitz
Journal:  Eur Radiol       Date:  2001       Impact factor: 5.315

Review 6.  Heterotopic ossification complicating critical illness.

Authors:  N C Clements; A E Camilli
Journal:  Chest       Date:  1993-11       Impact factor: 9.410

Review 7.  The prophylaxis and treatment of heterotopic ossification following lower limb arthroplasty.

Authors:  T N Board; A Karva; R E Board; A K Gambhir; M L Porter
Journal:  J Bone Joint Surg Br       Date:  2007-04

8.  Retroviral delivery of Noggin inhibits the formation of heterotopic ossification induced by BMP-4, demineralized bone matrix, and trauma in an animal model.

Authors:  David Hannallah; Hairong Peng; Brett Young; Arvydas Usas; Brian Gearhart; Johnny Huard
Journal:  J Bone Joint Surg Am       Date:  2004-01       Impact factor: 5.284

Review 9.  Molecular mechanisms of heterotopic ossification.

Authors:  Lee M Reichel; Elizabeth Salisbury; Michael J Moustoukas; Alan R Davis; Elizabeth Olmsted-Davis
Journal:  J Hand Surg Am       Date:  2013-11-15       Impact factor: 2.230

10.  Prophylaxis of heterotopic ossification - an updated review.

Authors:  Evan O Baird; Qian K Kang
Journal:  J Orthop Surg Res       Date:  2009-04-20       Impact factor: 2.359

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.